DR. JOSHI J ALUMKAL, MD
Osteopathic Medicine in Portland, OR
License number
Oregon D58757
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
3181 SW Sw Sam Jackson Park Rd Mail Code: :L586, Portland, OR 97239
Phone
(503) 494-8534
(503) 494-4285 (Fax)
(503) 494-6594
(503) 494-5385 (Fax)
(503) 494-4285 (Fax)
(503) 494-6594
(503) 494-5385 (Fax)
Personal information
See more information about JOSHI J ALUMKAL at radaris.comName
Address
Phone
2444 NE Cesar E Chavez Blvd, Portland, OR 97212
Organization information
See more information about JOSHI J ALUMKAL at bizstanding.comJoshi J Alumkal MD
3303 SW Bond Ave, Portland, OR 97239
Categories:
Family & General Practice Physicians & Surgeons
Phone:
(503) 494-8573 (Phone)
Professional information
See more information about JOSHI J ALUMKAL at trustoria.com
Joshi James Alumkal, Portland OR
Joshi James Alumkal, Portland OR
Specialties:
Oncologist
Address:
3181 Sw Sam Jackson Park Rd, Portland, OR 97239
3303 Sw Bond Ave, Portland, OR 97239
3303 Sw Bond Ave, Portland, OR 97239
Education:
Baylor University, College of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Dr. Joshi J Alumkal, Portland OR - MD (Doctor of Medicine)
Dr. Joshi J Alumkal, Portland OR - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Age:
50
Address:
Oregon Health Sciences University HO
3181 SW Sam Jackson Park Rd SUITE L58, Portland 97239
(503) 494-8534 (Phone)
3181 SW Sam Jackson Park Rd SUITE L58, Portland 97239
(503) 494-8534 (Phone)
Certifications:
Internal Medicine, 2001, Medical Oncology, 2004
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Education:
Medical School
Baylor College Of Medicine
Graduated: 1998
Sidney Kimmel Comp Cancer Center At Johns Hopkins
Baylor College Of Medicine
Graduated: 1998
Sidney Kimmel Comp Cancer Center At Johns Hopkins
Joshi James Alumkal, Portland OR
Joshi James Alumkal, Portland OR
Specialties:
Internal Medicine, Medical Oncology, Hematology & Oncology
Work:
Oregon Health & Science University
3181 SW Sam Jackson Park Rd, Portland, OR 97239 Oregon Health & Science University
3303 SW Bond Ave, Portland, OR 97239
3181 SW Sam Jackson Park Rd, Portland, OR 97239 Oregon Health & Science University
3303 SW Bond Ave, Portland, OR 97239
Education:
Baylor College of Medicine (1998)
Methods For The Selection Of Therapeutic Treatments For Cancer
Methods For The Selection Of Therapeutic Treatments For Cancer
US Patent:
2011019, Aug 11, 2011
Filed:
Oct 13, 2009
Appl. No.:
13/123236
Inventors:
Joshi Alumkal - Portland OR, US
International Classification:
G01N 33/573, G01N 21/64, G01N 21/76, C12Q 1/34
US Classification:
435 74, 435 18
Abstract:
Methods are disclosed for identifying subjects that would benefit from treatment with an inhibitor of HDAC6 deacetylase activity. The methods can include contacting a sample obtained from the subject with an of HDAC6 deacetylase activity detecting the amount of HDAC6 protein present in the tumor sample in comparison with a control. Such methods can be used to determine if a tumor in a subject is sensitive to treatment with an inhibitor of HDAC6 deacetylase activity. Also disclosed are methods for monitoring a response to a cancer treatment. Such methods are particularly useful in selecting a compound or multiple compounds for the treatment of cancer in a subject. Methods are also disclosed for identifying agents that inhibit cancer. The methods can include contacting at least one cell with a test agent and detecting an amount of HDAC6 protein in the cell in comparison to a control.
Methylation Markers For Prostate Cancer And Methods Of Use
Methylation Markers For Prostate Cancer And Methods Of Use
US Patent:
2010029, Nov 25, 2010
Filed:
May 14, 2008
Appl. No.:
12/600413
Inventors:
James Gordon Herman - Lutherville MD, US
Joshi Alumkal - Portland OR, US
Zhe Zhang - Owings Mills MD, US
Joshi Alumkal - Portland OR, US
Zhe Zhang - Owings Mills MD, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
A61K 38/20, C12Q 1/68, G01N 33/50, A61P 35/00
US Classification:
424 852, 435 6, 436 94
Abstract:
The present invention provides methods for identifying prostate cancer by detecting nucleic acid methylation of one or more genes in one or more samples. The invention further relates to DNA methylation as a predictor of prostate cancer recurrence and patient prognosis.